new glp 1 agonist novo nordisk Nordisk's weight-loss pill wins FDA approval Novo Nordisk expands oral GLP-1
Description
2 The American Association of Clinical Endocrinologists and American College of Endocrinology 2015 guideline does, however, give preference to GLP-1RA and SGLT2-I over older medication classes including SU and TZD

110 GLP-1RA contributes to gut microbiota composition and intestinal barrier integrity, which are associated with IBD development
Which class of NSAID do you see most often prescribed in your practice and why

2 In the full study population, breast cancer was diagnosed in 1.62% (247/15,264) of women with GLP-1 exposure compared with 2.47% (2,381/96,382) of women without exposure, corresponding to an odds ratio (OR) of 0.649 (95% CI, 0.5690.741

With "Retatrutide vs tirzepatide," the difference lies in its additional action on glucagon
